DOI QR코드

DOI QR Code

Epidemiological trends of gallbladder cancer in Australia between 1982 to 2018: A population-based study utilizing the Australian Cancer Database

  • Taha Mollah (Department of General Surgery, St. Vincent's Hospital Melbourne) ;
  • Marc Chia (Department of General Surgery, St. Vincent's Hospital Melbourne) ;
  • Luke C. Wang (Department of Surgery, Austin Health) ;
  • Prasenjit Modak (Department of Surgery, Swan Hill Hospital) ;
  • Kirby R. Qin (Department of Surgery, Austin Health)
  • Received : 2021.12.14
  • Accepted : 2022.01.17
  • Published : 2022.08.31

Abstract

Backgrounds/Aims: Gallbladder cancer (GBC) is a rare neoplasm. The epidemiology of GBC has not been updated in Australia for over five decades. Methods: Data of all Australian patients diagnosed with GBC at any age from 1982 to 2018 were identified from the Australian Cancer Database. Age-standardized rates were calculated and joinpoint analysis was performed to ascertain the trends of incidence and mortality of GBC. Results: Between 1982 and 2018, there were 22,745 cases of GBC and 11,054 GBC-related deaths in Australia. There were three distinct periods showing changed incidence. Period 1 (1982-1995) was stable. Period 2 (1996-2006) showed reduced incidence in females (3.6 to 2.8/100,000; p < 0.01) and all Australians (3.7 to 2.8/100,000, p < 0.01). Period 3 (2006-2017) demonstrated significantly increased incidence in all groups (males: 2.7 to 4.0/100,000, p < 0.01; females: 2.8 to 3.5/100,000, p < 0.01; all Australians: 2.8 to 3.7/100,000, p < 0.01). Incidence between females and males had declined from 1.10 : 1 in 1982 to 0.87 : 1 in 2017. There was a 71% reduction in mortality (3.1 to 0.9/100,000; p < 0.01). Median age at diagnosis increased from 69.7 to 74.3 years for females and from 67.2 to 73.3 years for males. Increasing incidence in the 6th to 8th decade of life in males, compared to previous years, was noted. Conclusions: Incidence, mortality, sex, and age of GBC have significantly changed in Australia since 1982. Rising incidence of GBC in Australia warrants further investigation.

Keywords

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-E386.
  2. Bennett RC, Jepson RP. Carcinoma of the gall-bladder. Aust N Z J Surg 1965;34:278-283.
  3. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomarkers Prev 2015;24:1319-1326.
  4. Wi Y, Woo H, Won YJ, Jang JY, Shin A. Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat 2018;50:1444-1451.
  5. Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: demographics, pathology and survival. ANZ J Surg 2002;72:857-861.
  6. Flemming JA, Zhang-Salomons J, Nanji S, Booth CM. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study. Cancer 2016;122:2534-2543.
  7. Cancer Research UK. Gallbladder cancer incidence statistics [Internet]. London: Cancer Research UK 2015 [cited 2021 Oct 10]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/gallbladder-cancer/incidence.
  8. Torre LA, Siegel RL, Islami F, Bray F, Jemal A. Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol 2018;16:427-437.
  9. Australian Institute of Health and Welfare. Australian Cancer Database (ACD) [Internet]. Darlinghurst: Australian Institute of Health and Welfare 2021 [cited 2021 Sep 27]. Available from: https://www.aihw.gov.au/about-our-data/our-data-collections/australian-cancer-database.
  10. Australian Institute of Health and Welfare. Cancer data in Australia [Internet]. Darlinghurst: Australian Institute of Health and Welfare 2021 [cited 2021 Sep 25]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/summary.
  11. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-351. Erratum in: Stat Med 2001;20:655.
  12. Hardy KJ. Laparoscopic cholecystectomy: Australian beginnings. ANZ J Surg 2011;81:866-870.
  13. Australian Institute of Health and Welfare. Procedures data cubes [Internet]. Darlinghurst: Australian Institute of Health and Welfare 2021 [cited 2021 Oct 8]. Available from: https://www.aihw.gov.au/reports/hospitals/procedures-data-cubes/contents/data-cubes.
  14. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99-109.
  15. Diehl AK, Beral V. Cholecystectomy and changing mortality from gallbladder cancer. Lancet 1981;2:187-189.
  16. Serra I, Yamamoto M, Calvo A, Cavada G, Baez S, Endoh K, Watanabe H, Tajima K. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer 2002;102:407-411. Erratum in: Int J Cancer 2003;104:798.
  17. Lee MH, Gao YT, Huang YH, McGee EE, Lam T, Wang B, et al. A metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer. Hepatology 2020;71:917-928.
  18. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006;118:1591-1602.
  19. Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol 2019;8:33.
  20. Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol 2019;5:93-102.
  21. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellof L. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol 1989;18:50-54.
  22. Australian Institute of Health and Welfare. Overweight and obesity [Internet]. Darlinghurst: Australian Institute of Health and Welfare 2020 [cited 2021 Oct 2]. Available from: https://www.aihw.gov.au/reports/australias-health/overweight-and-obesity.
  23. Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians [Internet]. Belconnen: Australian Bureau of Statistics 2018 [cited 2021 Oct 3]. Available from: https://www.abs.gov.au/statistics/people/aboriginal-and-torres-strait-islander-peoples/estimates-aboriginal-and-torres-strait-islander-australians/latest-release.
  24. Zhang X, Condon J, Dempsey K, Garling L. Cancer in the Northern Territory 1991-2010: incidence, mortality and survival. Darwin: Department of Health, 2014.
  25. Wigg AJ, Narayana SK, Hartel G, Medlin L, Pratt G, Powell EE, et al. Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia. EClinicalMedicine 2021;36:100919.
  26. Kamiza AB, Su FH, Wang WC, Sung FC, Chang SN, Yeh CC. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer 2016;16:861.
  27. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008;122:1849-1853.
  28. DiGiacomo M, Davidson PM, McGrath SJ, Dharmendra T, Thompson SC. Cancer in aboriginal and torres strait islander peoples: a rapid review of the literature. Sydney: UTS ePress, 2012.
  29. Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, et al. Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg 2021;91:603-608.
  30. Cocker F, Chien Yee K, Palmer AJ, de Graaff B. Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide. Aust N Z J Public Health 2019;43:267-273.
  31. Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982-2014: increasing incidence and improving survival. Liver Int 2019;39:522-530.
  32. Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, et al. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol Hepatol 2015;30:6-13.
  33. Mikaeel RR, Young JP, Hardingham JE, Tapia Rico G, Hewett PJ, Symonds EL, et al. Appendiceal neoplasm incidence and mortality rates are on the rise in Australia. Expert Rev Gastroenterol Hepatol 2021;15:203-210.